Analystreport

United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $195.00 price target on

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations